PASITHEA THERAPEUTICS CORP COM NEW

PASITHEA THERAPEUTICS CORP COM NEW is a security (CUSIP 70261F202) tracked across SEC portfolio filings. 20 institutional managers reported $8.6M on Form 13F as of 2026-06-30; 1 registered fund positions totaling $40K via N-PORT as of 2026-03-31.

Summary

Top institutional holders (Form 13F)

Showing 15 of 20 managers by value.

ManagerLocationValueShares
JANUS HENDERSON GROUP PLCLONDON, X0$1.6M2,100,000
Vivo Capital, LLCPalo Alto, CA$1.6M2,100,000
ADAGE CAPITAL PARTNERS GP, L.L.C.Boston, MA$1.6M2,100,000
Squadron Capital Management LLCWESTMONT, IL$1.6M2,100,000
Cable Car Capital, LPSAN FRANCISCO, CA$895K1,206,379
Stonepine Capital Management, LLCBend, OR$617K831,301
AdvisorShares Investments LLCBethesda, MD$250K337,508
Persistent Asset Partners LtdHONG KONG, K3$216K290,555
VANGUARD GROUP INCValley Forge, PA$126K97,675
GEODE CAPITAL MANAGEMENT, LLCBOSTON, MA$77K103,985
RENAISSANCE TECHNOLOGIES LLCNEW YORK, NY$69K93,399
XTX Topco LtdLONDON, X0$25K33,751
UBS Group AGZurich, V8$19K26,149
TWO SIGMA INVESTMENTS, LPNew York, NY$16K21,054
NORTHERN TRUST CORPCHICAGO, IL$14K19,372

Top fund holders (N-PORT)

FundRegistrantValue% of fund
VANGUARD EXTENDED MARKET INDEX FUNDVANGUARD INDEX FUNDS$40K0.00%

More